MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

Gian Paolo Tonini, Bruno De Bernardi, Andrea Pession et al.|Journal of Clinical Oncology|1997

Cited by 113